The Landscape of Kinase Domain Duplication (KDD) in Chinese Lung Cancer Patients

被引：0
|
作者：
Wang, P. [1 ]
Wu, D. [2 ]
Xie, Y. [3 ]
Shi, X. [4 ]
Hou, T. [5 ]
Chen, S. [5 ]
Xiang, J. [5 ]
Shao, L. [5 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Hangzhou, Peoples R China
[2] Shenzhen Peoples Hosp, Dept Resp Med, Shenzhen, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Thorac Surg, Shenzhen, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Dept Med Oncol, Fuzhou, Peoples R China
[5] Burning Rock Biotech, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
kinase domain duplication; lung cancer; Chinese;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P89.09
引用
收藏
页码：S691 / S692
页数：2
相关论文
共 50 条
  • [1] The landscape of kinase domain duplication in Chinese lung cancer patients
    Wu, Di
    Xie, Yuancai
    Jin, Chang'e
    Qiu, Jinfan
    Hou, Ting
    Du, Haiwei
    Chen, Songan
    Xiang, Jianxing
    Shi, Xi
    Liu, Junling
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [2] Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib
    Zhu, You-Cai
    Wang, Wen-Xian
    Xu, Chun-Wei
    Tan, Qing-He
    Li, Jian-Ying
    Zhuang, Wu
    Song, Zheng-Bo
    Du, Kai-Qi
    Chen, Gang
    Lv, Tang-Feng
    Song, Yong
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : E359 - E363
  • [3] EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib
    Gallant, Jean-Nicolas
    Sheehan, Jonathan H.
    Shaver, Timothy M.
    Bailey, Mark
    Lipson, Doron
    Chandramohan, Raghu
    Brewer, Monica Red
    York, Sally J.
    Kris, Mark G.
    Pietenpol, Jennifer A.
    Ladanyi, Marc
    Miller, Vincent A.
    Ali, Siraj M.
    Meiler, Jens
    Lovly, Christine M.
    [J]. CANCER DISCOVERY, 2015, 5 (11) : 1155 - 1163
  • [4] Lung Adenocarcinoma Patient with EGFR Kinase Domain Duplication (KDD) and Its Response to Icotinib: A Case Report
    Wang, W.
    Xu, C.
    Tan, Q.
    Song, Z.
    Zhuang, W.
    Chen, Y.
    Xiong, L.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2261 - S2261
  • [5] EGFR kinase domain duplication (EGFR-KDD) is activated by asymmetric intramolecular dimerization
    Du, Zhenfang
    Gallant, Jean-Nicolas
    Red-Brewer, Monica
    Brown, Benjamin
    Sheehan, Jonathan
    Meiler, Jens
    Lovly, Christine M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [6] Lung Adenocarcinoma Harboring EGFR Kinase Domain Duplication (EGFR-KDD) Confers Sensitivity to Osimertinib and Nivolumab: A Case Report
    Li, Jie
    Yan, Junrong
    Cao, Ran
    Du, Guanjun
    Zhao, Guofang
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] The Landscape of FGFR Alteration in Chinese Patients with Lung Cancer
    Wang, H.
    Ning, R.
    Zheng, H.
    Pan, Q.
    Yu, J.
    Zhang, J.
    Zhao, D.
    Wang, W.
    Zhang, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S570 - S571
  • [8] Clinical and Genomic Features of EGFR-KDD/EGFR Rearrangements of Chinese Lung Cancer Patients
    Zhou, C.
    Zhao, J.
    Gu, D.
    Chen, R.
    Xia, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S688 - S688
  • [9] Genomic landscape and clinicopathological characteristics of lung cancer in young Chinese patients.
    Zhang, Jiexia
    Tong, Xiaoling
    Bao, Hua
    Wu, Xue
    Wang, Xiaonan
    Shao, Yang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] The landscape of kinase fusions in 445 Chinese NSCLC patients
    Chen, M. W.
    Chen, H.
    Wang, M. H.
    Shou, T.
    Shi, Y. F.
    Guo, Q. S.
    Shang, Y. H.
    Hu, J.
    Liu, C.
    Dai, L.
    Zhang, P.
    Chirn, G. W.
    Wang, K.
    Yao, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 16 - 16
12345